International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 5.28.2020
2020mmbanner5.28.2020.jpg
blog-banner-asco-logo.jpg
A Virtual ASCO Meeting and a Real Pandemic
Were it not for the coronavirus pandemic, thousands of cancer researchers would have been descending on Chicago this weekend for the 56th Annual Meeting of the American Society of Clinical Oncology (ASCO). Instead, the meeting has moved online. What are the most important myeloma presentations on tap? From CAR T-cell therapies to new drug combinations, IMF Chairman Dr. Brian G.M. Durie shares his choices.
2020BlogButton.png
counselor-with-senior-woman.jpg
Learn About Financial Assistance Programs for Cancer Patients
If you are living with multiple myeloma and facing financial hardship, there may be financial assistance available for you. Learn more about the Cancer Support Community’s Cancer Emergency Fund, the Healthwell Foundation’s COVID-19 ancillary costs, or the Leukemia & Lymphoma Society’s COVID-19 Patient Financial Aid Program for potential financial resources. Also, Team Rubicon is offering food relief assistance. As always, contact the IMF’s InfoLine at 1-800-452-2873 in the U.S. and Canada and 1-818-487-7455 globally to learn about any of these options.
2020LearnMoreButton.png
650x325hawaiiVilla.jpg
And This Too Shall Pass….
Once again, the IMF is hosting a raffle for a 10-day stay at the Villa Ono Oasis in historic Kailua-Kona, Hawaii. While many of us have been affected by COVID-19, we hope to remind you that this too shall pass. If you purchase the winning $50 raffle ticket, you could find yourself sipping a tropical beverage next to a private pool, just minutes from the Hawaiian coastline.
2020LearnMoreButton.png
convo-with-dr-durie-podcasst.jpg
Listen to This New Podcast
In this episode of “Conversations with Dr. Brian Durie,” Dr. Durie is joined by Dr. Suzanne Lentzsch of the New York-Presbyterian Hospital, and IMF Board Member and myeloma patient Yelak Biru. Listen as Dr. Suzanne Lentzsch describes her experience working on the front lines of the COVID-19 pandemic in New York City, while Yelak Biru dives into the myeloma patient mindset.
2020ReadNowButton.png
650x325advocacyWriting.jpg
Cancer Drug Parity Act Press Coverage
The Cancer Drug Parity Act has been getting a lot of attention in the press as a result of the COVID-19 pandemic. The pandemic has increased the urgency for legislation that will allow patients to more easily access orally administered cancer medications and keep them safe at home. Dozens of people — both patients and medical professionals — have shared their stories with the press. Click the button to read news about the bill and how it will help patients now.
2020LearnMoreButton.png
bdngrantcropped.jpg
Calling All Researchers: Submit Your Grant Applications
The Brian D. Novis Research Grants honor the IMF’s founder Brian Novis, who succumbed to multiple myeloma in July of 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The 2021 grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. The deadline to receive the applications is Saturday, August 1, 2020.
2020ButtonApplyNow.png
COVID19-revlimid-maintenance.jpg
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

COVID-19 FAQ #12: If a myeloma patient takes Revlimid® (lenalidomide) as maintenance treatment, should this patient continue with that treatment during the pandemic?
Watch Now
 
Clinical Trials

OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)


Search the Myeloma Matrix 2.0

Smart Patients: Join the Conversation
Upcoming Events
IMF Patient & Family Webinar Replay
Myeloma and Coronavirus

Hawaiian Vacation Raffle
Kailua-Kona, Hawaii

Hatfield Hike
Appalachian Trail

Click here to see all events
 

We Thank Our Sponsors:

Amgen, Bristol-Myers Squibb, Genentech, GSK, Sanofi-Genzyme, and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
2020ButtonDonateBurg.png
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma

www.myeloma.org
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page